These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15449774)

  • 1. [Comparative effectiveness of different methods of diagnosis and correction of impaired portal circulation].
    Tadzhiev IIa; Sergienko VB; Tsodikov GV; Tadzhieva NI; Topchiashvili ZA; Sapozhkova LP; Geĭnits AV
    Klin Med (Mosk); 2004; 82(7):43-5. PubMed ID: 15449774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
    Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
    Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M; Sacerdoti D; Merkel C; Gatta A
    J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
    Tincani E; Cioni G; Cristani A; D'Alimonte P; Vignoli A; Abbati G; Ventura P; Romagnoli R; Ventura E
    J Ultrasound Med; 1993 Sep; 12(9):525-9. PubMed ID: 8107184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
    Piscaglia F; Donati G; Gaiani S; Gramantieri L; Leoni S; Mancini M; Bolondi L
    Dig Liver Dis; 2004 Sep; 36(9):594-602. PubMed ID: 15460844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
    Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
    Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
    Piscaglia F; Gaiani S; Siringo S; Gramantieri L; Serra C; Bolondi L
    Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
    Jenkins SA; Shields R
    J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
    Wruck U; Wermke W
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.